Author: OurCrowd

[Edity Therapeutics in WebWire] Edity Therapeutics enters into a strategic co-development partnership with Aurigene Oncology to advance a novel cell therapy program for solid tumors

Edity Therapeutics and Aurigene Oncology Limited (AOL), a wholly-owned subsidiary of Dr. Reddy’s Laboratories Limited, a clinical-stage biotechnology company, announced a strategic collaboration to create novel cell therapy medicines for difficult-to-treat solid tumors. Read...

Read More

[data.world in PR Newswire] data.world announces partnership to enhance national biosurveillance capabilities

AUSTIN, Texas, April 3, 2025 /PRNewswire/ — data.world, the enterprise data catalog platform built for the AI era, today announced a strategic partnership with KUNGFU.AI and Cyberhill Partners to develop advanced biosurveillance analytics capabilities for government agencies. The initiative will combine data.world’s knowledge graph-based catalog platform with artificial intelligence to help analysts better identify and respond to potential biological threats. Read more...

Read More